Veronique Amor-Baroukh

Veronique Amor - Baroukh is a seasoned professional in the field of cellular and molecular biology, currently serving as Senior Director of Operations, Head of CMC, and Head of Development at Enlivex Therapeutics since July 2015. The company focuses on specialized cell immunotherapy aimed at moderating immune hyper responses. Prior to this role, Veronique Amor - Baroukh was a Research Team Leader and a PhD student at the Weizmann Institute of Science from 2007 to June 2015, where research was conducted in the Department of Molecular Cell Biology under Prof. Elior Peles. Educational qualifications include a PhD in Cell/Cellular and Molecular Biology and an MSc in Molecular Biology from the Weizmann Institute, along with a BSc in Microbiology and Immunology from McGill University, where Veronique Amor - Baroukh graduated with honors.